JP Morgan Chase
ORGO icon

JP Morgan Chase’s Organogenesis Holdings ORGO Stock Holding History

JP Morgan Chase’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,700
Closed -$138K – 6872
2021
Q3 		$138K Buy
+9,700
New +$151K ﹤0.01% 5412

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JP Morgan Chase's ORGO Position: Q2 2026 in Review

JP Morgan Chase increased its Organogenesis Holdings (ORGO) stake by 2.5% in Q2 2026, buying an estimated $1.72K and bringing the position to 28,692 shares worth $69.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6278.

JP Morgan Chase first reported a position in ORGO in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.99M in Q2 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • JP Morgan Chase held 28,692 shares of Organogenesis Holdings worth $69.4K as of Q2 2026.
  • JP Morgan Chase bought 703 Organogenesis Holdings shares in Q2 2026, an estimated $1.72K.
  • Organogenesis Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6278 holding.
  • JP Morgan Chase first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 30 quarters since.
  • JP Morgan Chase's Organogenesis Holdings position peaked at $1.99M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.